Dr. Craig Washington, MD

NPI: 1043731946
Total Payments
$224,755
2024 Payments
$89,500
Companies
33
Transactions
336
Medicare Patients
1,108
Medicare Billing
$136,441

Payment Breakdown by Category

Consulting$217,954 (97.0%)
Food & Beverage$4,284 (1.9%)
Travel$2,517 (1.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $217,954 116 97.0%
Food and Beverage $4,284 209 1.9%
Travel and Lodging $2,517 11 1.1%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $220,610 132 $0 (2024)
Novo Nordisk Inc $643.17 35 $0 (2024)
Lilly USA, LLC $405.03 24 $0 (2024)
Amgen Inc. $367.19 13 $0 (2024)
ABBVIE INC. $362.46 16 $0 (2024)
PFIZER INC. $347.09 18 $0 (2024)
E.R. Squibb & Sons, L.L.C. $198.36 8 $0 (2018)
Medtronic, Inc. $175.34 3 $0 (2023)
AstraZeneca Pharmaceuticals LP $172.06 9 $0 (2024)
Janssen Pharmaceuticals, Inc $166.93 8 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $89,500 118 Takeda Pharmaceuticals U.S.A., Inc. ($88,365)
2023 $45,412 100 Takeda Pharmaceuticals U.S.A., Inc. ($43,820)
2022 $48,785 59 Takeda Pharmaceuticals U.S.A., Inc. ($48,140)
2021 $38,329 37 Takeda Pharmaceuticals U.S.A., Inc. ($37,902)
2020 $2,384 5 Takeda Pharmaceuticals U.S.A., Inc. ($2,384)
2018 $240.04 11 E.R. Squibb & Sons, L.L.C. ($142.22)
2017 $105.73 6 E.R. Squibb & Sons, L.L.C. ($56.14)

All Payment Transactions

336 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,616.65 General
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,193.33 General
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,093.33 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,193.33 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,093.33 General
10/30/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $24.39 General
Category: Diabetes
10/15/2024 Boehringer Ingelheim Pharmaceuticals, Inc. SYNJARDY (Drug) Food and Beverage In-kind items and services $22.03 General
Category: DIABETES
10/10/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $16.76 General
Category: Oncology
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,193.33 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,093.33 General
10/03/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $15.13 General
Category: Diabetes
10/01/2024 SHIELD THERAPEUTICS INC ACCRUFER (Drug) Food and Beverage In-kind items and services $18.61 General
Category: Hematology
09/23/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $22.34 General
Category: Inflammation
09/18/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $21.45 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/18/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $14.09 General
Category: GASTROENTEROLOGY
09/12/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $13.91 General
Category: Inflammation
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,093.33 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,093.33 General
09/09/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $28.33 General
08/30/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $23.05 General
08/29/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $14.94 General
Category: DIABETES
08/26/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $24.14 General
Category: NEUROSCIENCE
08/19/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $19.77 General
Category: Cardiology/Vascular Diseases
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,093.33 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,093.33 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 425 714 $187,686 $58,390
2022 10 463 666 $156,178 $56,416
2021 5 220 263 $43,217 $21,634
Total Patients
1,108
Total Services
1,643
Medicare Billing
$136,441
Procedure Codes
24

All Medicare Procedures & Services

24 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 154 410 $121,770 $34,881 28.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 84 116 $24,592 $7,409 30.1%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 27 27 $10,449 $4,979 47.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 41 41 $15,867 $4,595 29.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 22 22 $6,688 $3,186 47.6%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 20 20 $2,660 $1,516 57.0%
G0008 Administration of influenza virus vaccine Office 2023 22 22 $1,100 $761.86 69.3%
93922 Ultrasound study of arm and leg arteries Office 2023 16 16 $3,200 $737.78 23.1%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 39 40 $1,360 $324.41 23.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 144 265 $78,705 $28,275 35.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 115 194 $41,128 $12,234 29.7%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 24 24 $9,288 $4,562 49.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 27 27 $8,208 $4,031 49.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 27 27 $10,449 $3,448 33.0%
93922 Ultrasound study of arm and leg arteries Office 2022 13 14 $2,800 $1,139 40.7%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2022 12 12 $1,596 $839.18 52.6%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 61 63 $2,142 $797.03 37.2%
G0008 Administration of influenza virus vaccine Office 2022 17 17 $850.00 $589.76 69.4%
G0444 Annual depression screening, 15 minutes Office 2022 23 23 $1,012 $500.26 49.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 69 83 $18,343 $9,482 51.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 85 113 $16,724 $9,114 54.5%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 15 15 $4,950 $2,160 43.6%
G0444 Annual depression screening, 15 minutes Office 2021 20 20 $800.00 $443.40 55.4%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 31 32 $2,400 $434.31 18.1%

About Dr. Craig Washington, MD

Dr. Craig Washington, MD is a Internal Medicine healthcare provider based in Frederick, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2017. The National Provider Identifier (NPI) number assigned to this provider is 1043731946.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Craig Washington, MD has received a total of $224,755 in payments from pharmaceutical and medical device companies, with $89,500 received in 2024. These payments were reported across 336 transactions from 33 companies. The most common payment nature is "Consulting Fee" ($217,954).

As a Medicare-enrolled provider, Washington has provided services to 1,108 Medicare beneficiaries, totaling 1,643 services with total Medicare billing of $136,441. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties General Practice
  • Location Frederick, MD
  • Active Since 06/29/2017
  • Last Updated 06/11/2025
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1043731946

Products in Payments

  • ELIQUIS (Drug) $298.43
  • MOUNJARO (Drug) $289.21
  • Ozempic (Drug) $198.09
  • UBRELVY (Drug) $177.43
  • Otezla (Drug) $174.64
  • XARELTO (Drug) $166.93
  • Rybelsus (Drug) $162.34
  • Cologuard Collection Kit (Device) $159.26
  • PREVNAR 20 (Biological) $145.98
  • Kerendia (Drug) $145.25
  • Repatha (Biological) $137.22
  • QULIPTA (Drug) $133.18
  • RYBELSUS (Drug) $125.60
  • NURTEC ODT (Drug) $121.15
  • FARXIGA (Drug) $92.26
  • INTELLIS ADAPTIVESTIM (Device) $90.40
  • ClosureFast (Device) $84.94
  • ACCRUFER (Drug) $76.54
  • JARDIANCE (Drug) $73.55
  • TRELEGY ELLIPTA (Drug) $72.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Frederick